EUTM file information

018689083


April 18, 2022

Trademark Summary

The trademark application was filed by Takeda Pharmaceuticals International AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on May 12, 2022, and it was registered by office on August 19, 2022 without any oppositions.

The application was filed in English (German was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with Pharmaceutical preparations for the treatment of the consequences of genetic disorders.
Trademarkers